Tianjin TEDA Biomedical Engineering Company Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 398 million compared to CNY 403.73 million a year ago. Net loss was CNY 20.16 million compared to CNY 27.45 million a year ago.

Basic loss per share from continuing operations was CNY 0.0077 compared to CNY 0.0132 a year ago. Basic loss per share was CNY 0.0106 compared to CNY 0.0145 a year ago.